Sept 28 (Reuters) -
* U.S. judge dismisses Bayer AG patent lawsuit against Watson
Pharmaceuticals Inc Novartis ag's sandoz unit over yasmin
contraceptive - court ruling
* Bayer had alleged that defendants infringed patent by seeking U.S. approval
to market generic versions of yasmin
* Judge says Bayer patent does not claim a use for yasmin that has been
approved by U.S. FDA
* Judge dismisses bayer's patent infringement claims with prejudice
(New York Equities Desk; tel: +1 646 223 6000) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* U.S. judge dismisses Bayer AG patent lawsuit against Watson
Pharmaceuticals Inc Novartis ag's sandoz unit over yasmin
contraceptive - court ruling
* Bayer had alleged that defendants infringed patent by seeking U.S. approval
to market generic versions of yasmin
* Judge says Bayer patent does not claim a use for yasmin that has been
approved by U.S. FDA
* Judge dismisses bayer's patent infringement claims with prejudice
(New York Equities Desk; tel: +1 646 223 6000) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.